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Introduction
Considering the allograft rejection as one of the basic fea-
tures of the immune system, the mammalian pregnancy is
still a puzzling situation where the semiallogeneic
embryo, a mating product of non-histocompatible indi-
viduals is not rejected. How are the demands of pregnancy
solved in the context of the maternal immunity? How is
the competent maternal immune system modulated dur-
ing pregnancy? These are hard questions to answer and an
intriguing challenge for immunologists to explain. Histor-
ically, the mammalian fetus has been regarded as a suc-
cessful allograft, a tumor or a parasite [1,2]. Although the
mechanisms that promote the survival of the conceptus
are at large still unknown, it has become increasingly clear
that the maternal immune tolerance towards the fetus is
the result of the interactions of a jigsaw puzzle of actors –
cells, serum proteins, hormones, cytokines, enzymes and
neurotransmitters.
The fetus is never in direct contact with uterine/maternal
tissues. Instead, the contact is mediated through the pla-
centa, a transient organ expressing preferentially paternal
genes. Placental trophoblast cells come in close contact
with the maternal tissues forming the so-called feto-
maternal interface. There is no doubt that the maternal
immune system is able to recognize and react to fetally
derived antigens. However, the fetus is recognized in such
a way that the major histocompatibility complex (MHC)
– specific, acquired arm of the maternal immunity is sup-
pressed [3,4]. Instead, the maternal innate, first-line
defense immune mechanisms are used and promoted
during gestation [5,6]. The γδT cells are an important com-
ponent of the innate immune system recognizing allo-
and/or self-antigens upon cell infection, stress or transfor-
mation. Both an effector and a regulatory role for γδT cells
in vivo are well documented. Their overall function is to
maintain homeostasis in the tissues where they reside
[7,8]. The constitutive presence of γδT lymphocytes at the
feto-maternal interface [9-11] implies a possible role in
the adaptation of the maternal immune system to the
requirements of pregnancy.
The leukocyte population at the feto-maternal 
interface – decidua associated lymphoid tissue 
(DALT)
The decidual associated lymphoid tissue in human early
pregnancy, DALT, is shown in Fig. 1 after staining with the
leukocyte common antigen CD (cluster of differentiation)
45. As can be seen the immune cells are abundant in
decidua. Approximately 10–15 % of all decidual cells
belong to the lymphoid cell lineages [11]. DALT com-
prises mainly of CD56+/CD16- natural killer (NK)-like
cells, T cells bearing T-cell receptor (TCR) αβ or TCRγδ,
dendritic cells and macrophages [11]. B cells are scarce or
absent. The human DALT consist of lymphoid cell clusters
(LCCs) of closely packed activated cells, subepithelially
positioned cells in close contact with the basolateral por-
tion of the glandular epithelium and individual cells ran-
domly dispersed between the stromal cells [11]. In
contrast to the gut mucosa, there are no truly intraepithe-
lial lymphocytes in decidua; i.e. immune cells located
above the basal membrane and between the glandular
epithelial cells. However, numerous decidual lym-
phocytes, both CD56+ and T cells are localized in close
vicinity of the basal membrane of the glandular
epithelium.
The largest of the leukocyte populations in decidua are the
bone marrow derived CD56+bright/CD16-  NK-like large
granular lymphocytes (LGLs). These cells populate the
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uterine mucosa prior to implantation suggesting that the
fetus does not play a direct role in their homing to the
endometrium. Instead, circumstantial evidence implicates
ovarian steroids and uterine decidualization as the main
factors for the homing process [12]. Their phenotype is
CD16- CD56+bright CD57- CD2+ CD3-CD7+ CD4- CD8-, c-
kit+, CD94+, resembling that of the circulating CD56+bright/
CD16- NK cells [in [13]]. The murine counterpart of the
CD56+bright cells does not express the CD56 molecule and
its phenotype is Thy 1.1+, asialo-GM1+, interleukin (IL)-
15R+[14]. The CD56+bright/CD16- decidual NK cells pro-
duce a variety of cytokines, including granulocyte-macro-
phage-colony stimulating factor (GM-CSF), transforming
growth factor (TGF) β1, interferon (IFN) γ, tumor necrosis
factor (TNF) α, IL-2 and leukemia inhibitory factor (LIF)
[15].
Although extensively studied the role of the CD56+bright/
CD16- cells in human pregnancy is not yet established. In
mice, a role for the decidual NK-like cells in the modifica-
tion of the uterine blood vessels in the process of placenta
formation has recently been suggested [16]. In humans,
an intriguing observation is that the CD56bright+/CD16-
cells, numerous at early pregnancy, drastically drop at the
second and third trimester and are practically absent at
term. Moreover, they express c-kit and the recombinase
activating genes (RAG) 1 and RAG2, suggesting TCR rear-
rangement processes or/and a progenitor nature of these
cells [13,17,18].
General characteristics of the γδT cells
Two lineages of T lymphocytes can be defined by their
expression of TCR-TCRαβ- and TCRγδ cells. The TCRαβ
cells comprise the majority of T lymphocytes in the blood
Immunohistochemical staining of immune cells in human early pregnancy decidua with monoclonal antibody against the leuko- cyte common antigen CD45 showing the histologic organization of DALT Figure 1
Immunohistochemical staining of immune cells in human early pregnancy decidua with monoclonal antibody against the leuko-
cyte common antigen CD45 showing the histologic organization of DALT. LCC = lymphoid cell cluster, G = endometrial /
decidual gland, V = vessel. Magnification × 32.
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and lymphoid tissues. About 90 to 95% of circulating T
cells use the TCRαβ while 5–10% use the alternate het-
erodimeric TCR composed of γ and δ chains. A portion of
the γδT cells are generated in the thymus, but a major frac-
tion appear to be generated in an extrathymic compart-
ment [19]. Since their discovery during the 1980s, the γδT
cells have been a focus for extensive research but still
remain an enigma. In adult animals and humans γδT cells
can be roughly divided into two groups – (i) circulating
lymphocytes comprising 1–10% of the peripheral blood
mononuclear cells and (ii) resident cells of the mucosal
surfaces of the digestive-, respiratory-, urogenital tracts
and the murine skin. In some reports the γδT cells are as
abundant as 50% of the T cells in the murine skin epithe-
lia or gut mucosa [7,20]. The αβ- and γδT cells, seem to be
different in their immune biology and belong to separate
branches of the immune system – the TCR γδ cells act like
innate immune cells while the TCRαβ cells play a central
role in the adaptive immune system [21]. The major prop-
erties of the TCR αβ and γδ cells are shown in Table 1.
Vδ usage – a landmark for circulating and resident γδT cells
One major difference between the circulating and resident
γδT cells is that they are using different variable (V) δ
chains – the resident γδT cells are Vδ1+ while the circulat-
ing counterpart is Vδ2+[20]. Recent studies of the pheno-
type of these two subsets in humans reveal that the Vδ2+
cells are similar in surface markers to the αβT cells while
Vδ1 T cells have a phenotype more like mucosal lym-
phocytes and IELs [reviewed in [20]]. Resident γδT cells in
epithelia are quite different in T-cell receptor repertoire
and distribution from circulating γδT cells or αβT cells.
These cells take up residence in the epithelial surfaces of
the lung, intestine, uterus, vagina, tongue and murine skin
[20]. Although γδT cells develop in a thymic dependent
manner, resident γδT cells can be thymus-independent
and are detectable in athymic mice. Fetal liver and bone
marrow progenitors can reconstitute the resident intraep-
ithelial lymphocytes (IELs) in thymectomized recipients
suggesting an alternative developmental pathway for the
resident γδT cells [22]. Thus, these two γδT cell subsets
may develop from distinct lineages.
Antigen recognition by γδT cells
What do γδT cells see? Unlike the αβT cells, the TCRγδ
cells are not MHC restricted. They seem to recognize anti-
gens in a fundamentally different way than that of αβT
cells, more similar to antibodies [7,21]. Furthermore,
there are differences in the recognition pattern of the cir-
culating and resident γδT cells. Human resident Vδ1+ T
cells seem to be inherently self-reactive. Some of these
cells recognize CD1c, a member of non-polymorphic cell-
surface glycoproteins structurally and evolutionarily
related to MHC class I molecules. It is not clear if the
CD1c-reactive Vδ1+  cells respond to CD1c molecules
alone or with a self-lipid molecule [23]. Vδ1+ cells have
also been shown to recognize the newly defined MHC
class I chain-related sequences A and B (MICA and MICB).
These antigens are restricted to certain cell types of epithe-
lial origin and are modulated by stress, inflammation,
infection and cancer [7,20,24,25].
In contrast to resident γδT cells, the human circulating γδT
cells have been shown to recognize non-peptide antigens
derived from microbes and plants. The well-defined non-
peptide antigens recognized by circulating γδT cells are
prenyl pyrophosphates, bisolphonates, and alkylamines
[20]. Thus, the recognition manner of γδT cells is depend-
ent of the Vδ usage.
Table 1: Comparison between TCRγδ and TCRαβ lymphocytes
Comparison between the γδT and αβT lymphocyte lineage
Characteristics γδT lymphocytes αβT lymphocytes
Resident Circulating
Immunity affiliation innate innate/adaptive(?) adaptive
Ontogeny develop earlier develop earlier develop later
Development thymus/ extra-thymus thymus thymus/extra-thymus
Ag-receptor configuration CD3+Vδ1 CD3+Vδ2C D 3 + T C R αβ
Phenotype different from αβT cells similar to αβT cells
CD4-/CD8- (most) CD4-/CD8- (most) CD4+ or CD8+
CD8+ or CD8αα (some)
MHC restriction no no yes
Antigen recognition self-antigens non-peptide antigens from bacteria and plants peptide+MHC
Frequency in blood very few 1–10% 65–75%
Tissue distribution mucosae, epithelia, lymphoid tissues blood lymphoid tissues (?) blood, lymphoid tissues, mucosae
Effector functions cytotoxic potency cytotoxic potency cytotoxic potency
cytokine release cytokine release cytokine release (Th1/Th2)
Biological functions immunoregulation pathogen eradication pathogen eradication
immunosurveillance immune protection
pathogen eradication
wound repair (mice)Reproductive Biology and Endocrinology 2003, 1 http://www.rbej.com/content/1/1/120
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Functional characteristics of the γδT cells
What do the γδT cells do? The function of the γδT cells
should again be discussed in the context of their location
in the blood or in the tissues. Various mucosae are the nat-
ural habitat of resident, Vδ1+γδT cells. It is however not
known if these cells take up residence as naive or as anti-
gen-experienced memory-type of cells. Several reports
[20,26] have shown that resident γδT cells express cyto-
toxic molecules-perforin, granzymes and Fas ligand.
Chemokines such as lymphotactin, MIP-1α and MIP-1β,
the chemokine receptors CCR5 and CXCR3 and adhesion
molecules are also expressed by γδT cells [20]. Taken
together, these data indicates the "activated yet resting"
state of the γδT cells. The ability of the resident γδT cells to
rest but at the same time display molecules engaged in
effector functions is consistent with the presumption that
these cells function as first-line defense rather than as a
component of the adaptive immunity.
The circulating γδT cells, on the other hand, can react rap-
idly with non-peptide antigens upon encountering infec-
tions and thereby activate the innate immune cells and
subsequently facilitate adaptive immune responses of αβT
cells. Several reports have shown that circulating Vδ2+ γδT
cells play a role in the elimination of infections with cer-
tain microbial pathogens such as intracellular bacteria like
Mycobacterium tuberculosis, Francisella tularensis, Legionella
micdadei, parasites like Plasmodium falciparum and Schisto-
soma Mansonii and the HIV virus [7,27,28]. Most studies
have shown that the γδT cells play a role in bridging innate
and adaptive immune responses. However, a fundamen-
tal question is whether circulating γδT cells have immuno-
logic memory and can contribute to adaptive immune
responses. In a non-human primate model of macaques
infected with Mycobacterium bovis (BCG) strain was shown
that circulating Vδ2+ cells which have undergone polyclo-
nal expansion during a primary BCG vaccination can
mount a memory/recall response following a secondary
BCG infection [reviewed in [20]]. These studies provide
evidence that Vδ2+cells like αβT cells are able to contrib-
ute to adaptive immune responses.
Accumulating evidence has been indicative of yet another,
not less important and sophisticated role for primarily the
resident γδT cells, than infection protection: tumor-sur-
veillance- and immunoregulatory functions [7,20,25,29].
Resident γδT cells may have a unique role in immune sur-
veillance against malignancy. This immune function may
have advantage over the αβT cells since resident γδT cells
can directly recognize molecules expressed on cancer cells
without antigen processing and presentation. The γδT cells
have the ability to migrate as infiltrating lymphocytes in
solid tumors [24,30] and have been shown to react on
inducible MICA/B molecules, thus recognizing and elimi-
nating damaged/malignant/stressed (epithelial) cells and
participating in the maintenance of homeostasis. Moreo-
ver, they can interact and modulate the activity of other
immune cells directly or by cytokine production and thus
function as regulatory cells. Although the exact mecha-
nisms of these functions remain unclear, their ability to
influence other immune cells provides them with the
opportunity to modulate the course and outcome of a
variety of immune and non-immune responses and to act
in different ways depending on the particular microenvi-
ronment in which they are present.
γδT cells in pregnancy
The immunological challenge of viviparity is to exert
immunosuppression of specific responses towards the
fetus without compromising the ability to fight infection.
From this point of view, the γδT cells, which combine
unique functions of infection protection and immunoreg-
ulation (Table 1), are of particular interest during preg-
nancy. Classical polymorphic MHC molecules are absent
in the trophoblast cells and class II molecules cannot be
induced even after stimulation with IFNγ [31], thus a
direct allostimulation of the maternal αβT cells is avoided.
In line with this finding it has been proposed that lack of
polymorphic MHC molecule expression on the trophob-
last is a way to "hide" pregnancy from the immune sys-
tem. There is, however, abundant hard evidence refuting
this hypothesis. The successful pregnancy is indeed recog-
nized by the immune system in a way promoting immu-
notolerance. TCRαβ-mediated recognition of fetal
antigens, restricted to classical MHC molecules might pro-
voke cytotoxic reaction toward the fetus and is unlikely to
be promoted. The γδT cells, however, recognize a distinct
group of ligands and antigens in a MHC-unrestricted
manner and might play a key role in the immunological
recognition of pregnancy.
Circulating γδT cells in human pregnancy
Human γδT cells in peripheral blood of women with nor-
mal pregnancy and recurrent abortions have been studied
by Szekerez-Bartho et al. In healthy pregnant women,
there was an accumulation of Vδ1+ circulating cells, in
contrast to women with recurrent abortions where the
Vδ2+ circulating cells dominated. The ratio of activated
γδTCR+ cells was significantly increased in normal preg-
nancies compared to that of recurrent abortions [32,33].
A bias towards circulating Vδ1+γδT cells seemed to be
required for a successful normal pregnancy [32,33].
However, the precise role of circulating γδT cells in preg-
nancy is not yet completely established. Although conven-
ient to study the γδT subsets during pregnancy in the
peripheral blood, it cannot be excluded that the circulat-
ing Vδ1+ cells might simply be a spill over from the feto-
maternal interface, where they are resident constitutive
inhabitants.Reproductive Biology and Endocrinology 2003, 1 http://www.rbej.com/content/1/1/120
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γδT cells at the feto-maternal interface
Phenotype and morphology
The γδT cells are present in endometrium of all mammals
throughout pregnancy [9]. It has been shown that these
cells specifically colonize the non-pregnant murine and
sheep endometrium and show a dramatic increase during
pregnancy suggesting a special role at the feto-maternal
interface [34]. The number of γδT cells in the uterus is
higher in allogeneic than syngeneic pregnancy, and the
expression of the TCRγδ in the pregnant uterus is shown
to be hormonally controlled [33]. The decidual γδT cells
are large granular lymphocytes rich in intracytoplasmic
granules and express neither CD4 nor CD8 (double nega-
tive) [10,11,13]. They are CD2+, express the activation
marker CD69, the memory/activation marker CD45RO,
the NK receptors CD94 [10,13] and NKG2D (manuscript
in preparation), and CTLA 4 (fig. 2), a marker associated
with regulatory T cells. The human γδT cells comprise a
heterogeneous population: double positive TCRγδ+/CD56
+ dim cells and TCRγδ single positive cells [13]. The coun-
terpart of these cells in the murine system seems to be the
TCRγδ+/ asialoGM+ cells and the single positive murine
γδT cells as described by Arck et al [2]. The surface density
of the TCR/CD3 is low in freshly isolated decidual γδT
cells (10, 35) but can be up-regulated in vitro [10].
The vast majority of the human decidual γδT cells are Vδ1+
[13,36]. Itohara et al. [37] and Heyborne et al. [42] have
shown that the Vδ1 chain is also preferentially used by γδT
cells in the uterus of normal and pregnant mice. Thus, the
γδT cells in pregnant uterine mucosa, like other mucosa-
associated γδT cells, are resident Vδ1+ cells.
Similar to resident γδT cells at other mucosal sites [20], the
decidual  γδT cells are activated but resting. We have
shown that they posses a cytotoxic potency and express
five major cytolytic molecules: perforin (Pf), granzyme A,
granzyme B, granulysin and Fas ligand (FasL), and store
them in microvesicles in intracytoplasmic cytolytic gran-
ules [26]. Like other cytotoxic lymphocytes [39] the decid-
ual γδT cells do not express FasL on their surface but store
preformed FasL in the granules, and can rapidly mobilize
it to the cell surface upon stimulation. Thus, the two
major cytotoxic mechanisms – Pf- and FasL-mediated –
are performed by one common secretory pathway based
on cytolytic granule exocytosis [26]. Cytotoxic mecha-
nisms play a crucial role in the clearance of viral and bac-
terial infections, tumor surveillance, transplant rejection,
homeostatic regulation of immune responses and periph-
eral tolerance [40]. Logically these mechanisms should
have an important function at the feto-maternal interface
by protecting the maternal-fetal unit against pathogens,
controlling invasion of placental trophoblast, and creat-
ing a local transient immunotolerance toward the semial-
logeneic conceptus through deletion of fetus-reactive
lymphocyte clones. Indeed, recent studies of Pf- and FasL-
deficient mice have shown that although functional dele-
tion of Pf or FasL alone does not appear to affect fertility,
Flow cytometric analysis of the regulatory cells-associated marker CTLA4 expression on freshly isolated, non-permeabilized  human decidual γδT cells from early normal pregnancy Figure 2
Flow cytometric analysis of the regulatory cells-associated marker CTLA4 expression on freshly isolated, non-permeabilized 
human decidual γδT cells from early normal pregnancy.Reproductive Biology and Endocrinology 2003, 1 http://www.rbej.com/content/1/1/120
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the combined absence of these two effector molecules
induces infertility [40].
Decidual γδT cells proliferate and differentiate in situ – decidua as 
an extrathymic maturation site
Interestingly, we were able to stain γδT cells in mitosis [13]
proving that the γδT cells divide in human decidua. As a
rule, the plasma membrane of the mitotic cells was
strongly stained with the reaction product indicating a
high level of γδT cell receptor expression [13]. Our finding
of γδT cells dividing in situ is in line with previous sugges-
tion that γδT cells might expand in epithelial sites exposed
to external environmental antigens, and, in some cases,
recognize self-antigens, specific to a particular local envi-
ronment [7,20,27]. By analogy, decidual Vδ1+ T cells may
recognize trophoblast-related antigens and be involved in
controlling trophoblast invasion during placenta forma-
tion [41].
In previous reports, Hayakawa et al. [17] in the human
system and Kimura et al. [18] in the murine system have
shown expression of mRNA for RAG-1 and RAG-2 pro-
teins, which are required for TCR rearrangement, in
human CD56bright/CD16- cells and in murine decidual
mononuclear cells respectively. We have confirmed and
extended these results showing that transcripts of RAG can
be easily detected in purified CD56+, CD2+, c-kit+ or IL-7R+
decidual cells implying an ongoing process of TCR gene
rearrangement [13]. There is no doubt that ongoing rear-
rangement of TCRγδ takes place in decidua, probably for
two purposes: 1) local extrathymic differentiation of γδT
cells by TCR receptor rearrangements and 2) secondary
TCRγδ rearrangement, permitting editing of antigen recep-
tors on mature cells, thus adjusting the decidual γδT-cell
repertoire to the ongoing pregnancy. Re-induced RAG
expression, involved in receptor editing is a phenomenon
observed in immature T cells in thymus and seems to be
Schematic presentation of the regulatory role of decidual γδT cells in human early pregnancy (with permission from ref. 50) Figure 3
Schematic presentation of the regulatory role of decidual γδT cells in human early pregnancy (with permission from ref. 50).
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required for the generation of normal T-cell repertoire
[42]. Although not proven yet it is reasonable to assume
that both local TCRγδ receptor rearrangement and editing
are equally used in decidua.
Is there a need for T-cell differentiation in decidua? What
purpose and biological significance there might be for
extrathymic T-cell differentiation during pregnancy?
We can argue for at least two different reasons for extrath-
ymic maturation in pregnancy. The first reason is priming
the maternal immune system to the fetus. The meeting
between the mother and the fetus is dual: 1) between the
maternal blood and syncytiotrophoblast cells of the chor-
ion villi of the placenta and 2) between the extravillous
trophoblast and the maternal epithelial, stromal,
endothelial and immune cells in decidua when placenta is
formed. It is reasonable to assume that the first encounter
and antigen presentation of fetal antigens to the immune
system takes place in decidua. Decidua/endometrium
might enrich CD56+ progenitor cells of bone marrow ori-
gin which will further differentiate/rearrange locally (or
naive thymus-derived T cells will edit their TCR) upon the
encounter of fetal antigens. The extrathymic maturation
in decidua might be one of the mechanisms adjusting the
immune system and the T-cell repertoire towards accept-
ance of the ongoing pregnancy. Heyborne et al have
shown that murine decidual γδT cells recognize trophob-
last-derived antigens. Immune cells, locally primed in
decidua might then repopulate the peripheral blood of
the pregnant woman as suggested by published reports
[reviewed in [32]].
The second reason for extrathymic maturation in decidua
might be the temporary thymic involution taking place
during pregnancy. A great loss in thymic weight during
Correlation between the cortex and medulla of thymus and its main functions in normal situation and in pregnancy Figure 4
Correlation between the cortex and medulla of thymus and its main functions in normal situation and in pregnancyReproductive Biology and Endocrinology 2003, 1 http://www.rbej.com/content/1/1/120
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pregnancy occurs due to increased cell death of small lym-
phocytes from the cortex. It appears that primarily CD4+/
CD8+ cortical thymocytes are lost whereas most other sub-
sets are retained; B-lymphopoiesis is depressed [43]. The
cortical involution is at its greatest by the end of
pregnancy and is maintained until lactation ceases. The
implications of the observed thymic changes can be
anticipated if they are correlated to the known thymic
function [[44], Fig. 4]. It is reasonable to assume that such
radical rearrangements are likely to have effects on the
maternal immune system and to influence the mother's
ability to protect the fetus from harmful maternal
responses to paternally inherited fetal antigens. The invo-
lution of cortex might mean deleting clones or unrespon-
siveness to paternally derived antigens [45]. It is tempting
to interpret the enlargement of the medulla as a potential
increase of regulatory T cells needed to modulate the
immune responses. Is there a role for decidua in the con-
text of the thymic involution during pregnancy? The
decidua as an extrathymic maturation site can be comple-
mentary to the thymic changes in at least two ways: 1) The
need for positive selection ablated by cortex involution
might be compensated for by extrathymic differentiation
of T cells which will be primed on pregnancy-derived anti-
gens in the decidual microenvironment and will allow to
eliminate/silence fetus-reactive T cell clones. 2) Naive T
cells generated in the medulla (e.g. regulatory cells) might
be re-edited in the decidua thus adjusting their T-cell
receptor repertoire to the ongoing pregnancy. The γδT
cells, differentiated locally in decidua [13,17,18], will thus
be specifically primed on the ongoing pregnancy.
The cytokine profile of the decidual γδT cells suggests regulatory 
functions
Cytokines at the fetomaternal interface play a pivotal role
for the establishment and maintenance of normal preg-
nancy. Several well-performed studies in humans and
mice have shown beyond doubt that there is a T-helper
(Th) 2 bias in the cytokine response [reviewed in [46]].
But the role of cytokines in pregnancy cannot solely be
explained by the Th2/Th1 paradigm. Although very
attractive, there is a serious risk of oversimplifying this
concept. First, a critical feature of the Th1/Th2 model is
that the two cell types counter regulate one another via
cytokine production. But the polarization of the Th1 ver-
sus Th 2 effector cells is rarely complete and simultaneous
Th1 and Th2 responses are possible. Second, this concept
is derived from results of in vitro experiments and experi-
mental models with immunologically inactive, inbred
laboratory mice. In reality, when faced with established
responses, the Th1 effectors have little ability to down-reg-
ulate Th2 responses [47]. Similarly, Th2 effector cells,
carefully separated from the Th2-like regulatory cells, have
been shown to aggravate, rather that inhibit Th1-medi-
ated inflammatory responses [47]. There is a compiling
body of evidence that the T-cell function at the feto-mater-
nal interface in successful pregnancy is modulated by a
cytokine environment of IL-10 and TGF-β, cytokines that
are not always viewed as Th2-type only [48]. Abandoning
the Th1/Th2 bias one can ask the question if other, non-
Th1/Th2 cells and responses operate at the fetomaternal
interface. Careful studies of decidual γδT cells in the
murine system have shown that, TCRγδ+/asialoGM1+ cells
and TCRγδ single positive cells [2] play a decisive role in
pregnancy outcome depending on their cytokine
response. At early preimplantation stage, murine γδT cells
Table 2: Summary of some characteristics of the T regulatory cells
T regulatory (TREG) cells
1. Definition Cells with regulatory function that produce IL-10 and TGF-β and play a critical role in the control 
the immune response and the generation and maintenance of tolerance.
2. Properties • heterogeneous group of lymphocytes
• exist in very low numbers
• respond poorly to stimulation through TCR
• unique and diverse mechanisms of action
• none common specific phenotypic marker
3. Some subtypes by phenotype • CD4+CD25+
• CD4+CD45RB+
• CD8+
• TCRγδ+
• NT/NKT cells – e.g. Vα24-JαQ
• CTLA4+
4. Subtypes by cytokine profile • Th3 cells: differentiate from naive CD4+ or CD8+ cells under the influence of TGF-β, produce 
TGF-β > IL-10, varying IL-4
• Tr1 cells: differentiate from naive CD4+ or CD8+ cells under the influence of IL-10, produce IL-10 
> TGF-β, no IL-4Reproductive Biology and Endocrinology 2003, 1 http://www.rbej.com/content/1/1/120
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produce TNF-α, IFN-γ and probably IL-2 and promote
abortions by activation of decidual NK cells and macro-
phages. At a later stage, during the time of implantation
and placenta formation, the γδT cells in murine decidua
produce TGF-β and IL-10 and exert anti-abortogenic effect
[2,49]. Using quantitative RT-PCR we have analyzed the
cytokine profile of the two main subpopulations of γδT
cells in human decidua: TCRγδ+/CD56+ and TCRγδ single
positive cells [10,13]. Our results [50] show that the
TCRγδ+/CD56+ cells almost exclusively express mRNA for
TGF-β1 and IL-10 cells suggesting orientation towards an
immunosuppressive profile [48]. Then as they further
develop into primed TCRγδ single positive cells their IL-10
and TGF-β1 expression is strongly enhanced. Addition-
ally, the TCRγδ single positive cells transcribe two more
cytokines-IL-6, suggesting an orientation toward the preg-
nancy-promoting Th 2 response and IL-1β, a cytokine
considered in general to have a function promoting mat-
uration and clonal expansion of other lymphocyte sub-
populations. In pregnancy in particular, IL-1β is
considered to be an important factor for the implantation
of the blastocyst in the uterine cavity acting through up-
regulation of adhesion molecule expression [51]. Our
results [50] based on quantitative cytokine mRNA meas-
urement in these two subpopulations of human decidual
γδT cells indicates that these cells, by virtue of the strong
dominance /exclusivity of IL-10/TGF-β mRNA expression
can be ascribed to the newly "reborn" suppressor/regula-
tory T (Treg) cells. Furthermore, these cells express the reg-
ulatory T cell marker CTLA4 (Fig. 2). A brief summary of
some of the characteristics of the Treg cells is given in
Table 2.
Recent data provide convincing evidence that a special-
ized population of Treg cells both do exist and play a crit-
ical role in the generation and maintenance of
immunological tolerance in humans [reviewed in
[48,52]]. The Treg cells exert their suppressive activities on
effector cells in remarkably low numbers [53]. Several
subsets of Treg cells have been described in a variety of
experimental models. In the context of this discussion it is
interesting to note that two human CD4+ Treg-cell subsets
exert their regulatory effect via secretion of the
immunosuppressive cytokines IL-10 and TGF-β. One sub-
set includes the so-called T helper 3 (Th3) cells, distin-
guished from other T helper cells by their ability to
produce high levels of TGF-β and varying levels of IL-10
and IL-4 [52]. The other subset, termed T regulatory type
1 (Tr1) cells produces a significant level of IL-10, various
levels of TGF-β and no IL-4 [54]. The decidual γδT cells
produce high amount of IL-10 followed by TGF-β and no
IL-4 [50] and thus belong to the Tr1 regulatory type of
cells. The selective generation of different Treg cell subsets
is determined by the cytokine microenvironment in
which naive CD4+ T cells encounter antigen. This means
that if priming of naive Th0 cells occurs in the presence of
IL-10 or TGF-β they differentiate to Tr1 or Th3 cells respec-
tively and become polarized to synthesis of IL-10 or TGF-
β [reviewed in [55]]. The cell type(s) responsible for the
creation of such unique cytokine microenvironments in
vivo is a subject of discussions. γδT cells are excellent can-
didates for this role, because these cells can respond to
broadly distributed self-antigens in stressed, damaged and
transformed tissues and do not require classical antigen
processing and MHC-restricted presentation [27]. γδT
cells have been implicated in the down regulation of
immune responses in various inflammatory disorders and
may acquire immunoregulatory properties at mucosal
sites [reviewed in [56]]. A population of γδT cells produc-
ing the Tr1/Th3 – type cytokines IL-10 and TGF-β has
been isolated from tumor-infiltrating lymphocytes. These
γδT cells could play a role in the inhibition of immune
responses to tumors [56]. It was shown that aerosol or
nasal inoculation of intact insulin resulted in expansion
of γδT cells with an immunosuppressive anti-diabetogenic
effect, mediated by IL-10 [56]. Remarkably, only a small
fraction of γδT cells was enough to prevent adaptive trans-
fer of diabetes [56]. Furthermore, γδT cells producing IL-
10/TGF-β were reported to be a critical cell population for
the induction of allograft- and testicular tolerance [57,58].
Summing up the accounted data above an attractive
hypothesis is that γδT cells act as cytokine-producing cells
to create a decidual environment that actively tolerates the
fetus [50]. We suggest that pregnancy-related antigen(s)
can activate decidual γδT cells causing them to release the
immunosuppressive Tr1- and Th3-type cytokines IL-10
and TGF-β. Figure 3 illustrates two possible mechanisms
by which these cells could induce local uterine tolerance
towards the fetus. In the direct pathway the effector cells
(cytotoxic T lymphocytes, NK cells, macrophages, den-
dritic and B cells) at the feto-maternal interface could be
directly inhibited by IL-10 and TGF-β[50]. In this pathway
γδT cells function as Treg cells [56]. In the indirect path-
way γδT cells could mediate the tolerogenic effect through
generation of primed Th0, mainly TCRαβ+ CD4+ (and
probably CD8+) cells. Under the influence of IL-10 and
TGF-β, these cells differentiate into IL-10 producing Tr1-
type of cells and TGF-β producing Th3 type of cells which
in their turn act suppressively on the effector cells. In this
pathway the γδT cells are needed for generation of efferent
suppressor cells, but are not suppressors themselves [56].
These two pathways might function in parallel and exert
immunosuppression in concert with each other. It cannot
be excluded that other types of decidual cells such as den-
dritic cells could also participate in the immunoregulation
[59]. The model presented [[50], Fig. 3] is simplified but
comprises one important mechanism for immunomodu-
lation at the feto-maternal interface.Reproductive Biology and Endocrinology 2003, 1 http://www.rbej.com/content/1/1/120
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Conclusions
An evolutionarily important process such as the mamma-
lian pregnancy is a paradox and a challenge for the
immune system and must rely on several mechanisms act-
ing in concert to modulate the maternal immunity. How-
ever, enough convincing evidence shows that the immune
system per se is not necessary for reproduction. Mammals
have to reproduce despite their immune system.
The dual mission of the immune system during pregnancy
is to down-regulate the specific, adaptive immune
responses without compromising the ability to fight infec-
tions and protect against tumor transformation. In this
process the innate immunity is activated and used to com-
pensate for the impairment of the adaptive immunity,
and to fulfill the requirements of a competent maternal
immune defense during pregnancy. From immunological
point of view pregnancy is a innate immunity event and
one of its components, the γδT cells with their unique
properties among the lymphoid cells of the immune sys-
tem, are particularly suited to effectuate in parallel specific
effector mechanisms combined with immunoregulatory
functions. The γδT cells in pregnancy are resident Vδ1+
lymphocytes that are permanent inhabitants of the decid-
ual mucosa. They comprise about half of the decidual T-
cell population, differentiate locally in uterus and thus
prime on the ongoing pregnancy. Activated but silent,
they have the potency to protect the feto-maternal unit
against stressed, infected and/or transformed cells. More-
over, they express high amounts of mRNA for the immu-
noregulatory cytokines IL-10 and TGF-β in a pattern
characteristic of Tr1 regulatory lymphocytes. This property
delineates their other major role in reproduction – to
function as direct or indirect immunosuppressors thus
modulating the maternal immune system towards toler-
ance of the fetus.
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